Canadian Medical Center Co (SAU:4021) Research & Development: ﷼0.0 Mil (TTM As of Mar. 2026)


SAU:4021 Canadian Medical Center Co SAU:4021
85 GF Score
Price ﷼5.57
GF Value ﷼10.69
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Canadian Medical Center Co Research & Development?

Canadian Medical Center Co SAU:4021 85 Research & Development is ﷼0.0 Mil as of Mar. 2026. GuruFocus rates SAU:4021 with a GF Score™ of 85/100 and a GF Value™ of ﷼10.69 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Canadian Medical Center Co's Research & Development for the three months ended in Mar. 2026 was ﷼0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼0.0 Mil.

Canadian Medical Center Co  (SAU:4021) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Canadian Medical Center Co Research & Development Related Terms

Canadian Medical Center Co Research & Development Historical Data

* Premium members only.

The historical data trend for Canadian Medical Center Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canadian Medical Center Co Research & Development Chart

Canadian Medical Center Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Canadian Medical Center Co Quarterly Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SAU:4021
85GF Score
Canadian Medical Center Co SAU:4021
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Canadian Medical Center Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ﷼0.0 Mil mean?
Canadian Medical Center Co (SAU:4021) has a Research & Development of ﷼0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Canadian Medical Center Co and its competitors.
Is Canadian Medical Center Co's Research & Development too high?
Canadian Medical Center Co's current Research & Development is ﷼0.0 Mil. Overall, Canadian Medical Center Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Canadian Medical Center Co's Research & Development compare to HCA and THC?
Canadian Medical Center Co's Research & Development of ﷼0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Canadian Medical Center Co and its competitors. Canadian Medical Center Co's current Research & Development is ﷼0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canadian Medical Center Co stock overvalued right now?
Based on GuruFocus' analysis, Canadian Medical Center Co (SAU:4021) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼10.69, compared to a current price of ﷼5.57 — trading 47.9% below its estimated fair value. The current Research & Development is ﷼0.0 Mil. Canadian Medical Center Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Canadian Medical Center Co (SAU:4021), the current Research & Development is ﷼0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Canadian Medical Center Co (SAU:4021) Overvalued in 2026?

Based on GuruFocus' analysis, Canadian Medical Center Co stock appears to be undervalued. The current stock price of ﷼5.57 is trading 47.9% below its estimated GF Value™ of ﷼10.69. GuruFocus considers Canadian Medical Center Co to be Significantly Undervalued.

Key valuation signals for SAU:4021:

  • Research & Development: ﷼0.0 Mil
  • GF Value™: ﷼10.69 vs. price of ﷼5.57 (47.9% below fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the SAU:4021 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Canadian Medical Center Co Business Description

Address Al-Ammar Avenue, Omar bin al Khattab Street, Building No. 1, Uhud, Dammam, SAU
Canadian Medical Center Co is a provider of emergency medical care solutions and integrated healthcare services management. The company offers a wide range of medical services, including operating on-site clinics, medical coverage for events and projects, and ambulance transportation services supported by a fleet of modern ambulances and trained and licensed medical teams. Its services include Medical Centers, Medical Support at Onshore and Offshore Sites, Medical Support at Construction Sites, Medical Support at Industrial Sites, Medical Coverage for Events, Ambulance Services, Home Health Care, Medical Training, Medical Examinations, and Ambulance Transports.
85GF Score

Get the complete analysis for SAU:4021

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼5.57
Price
﷼10.69
GF Value